Hong Kong vs Nicaragua: Life science patents granted, by technology
Hong Kong
54 patents
in 2020
Nicaragua
36 patents
in 2021
Hong Kong rank
21st
Nicaragua rank
24th
Life science patents granted, by technology over time
- Hong Kong
- Nicaragua
How they compare
Hong Kong currently reports 54 patents against 36 patents in Nicaragua, a difference of 18 patents.
That makes Hong Kong's figure about 1.5 times Nicaragua's.
The two have swapped places 4 times across 18 shared years of data; in 2003 it was Hong Kong ahead.
Hong Kong ranks 21st and Nicaragua ranks 24th of 65 countries.
Across the 3 decades both report, Hong Kong averaged higher in 2 and Nicaragua in 1.
Head to head by decade
| Decade | Hong Kong | Nicaragua | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 98.43 patents | 12.57 patents | 85.86 patents | Hong Kong |
| 2010s | 10.7 patents | 63.1 patents | 52.4 patents | Nicaragua |
| 2020s | 54 patents | 37 patents | 17 patents | Hong Kong |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher life science patents granted, by technology, Hong Kong or Nicaragua?
- Hong Kong, at 54 patents against 36 patents in Nicaragua as of 2020.
- What is the difference in life science patents granted, by technology between Hong Kong and Nicaragua?
- 18 patents, with Hong Kong ahead.
- How many years of comparable data are there for Hong Kong and Nicaragua?
- 18 years are reported by both, from 2003 to 2020.
- How do Hong Kong and Nicaragua rank globally for life science patents granted, by technology?
- Hong Kong ranks 21st and Nicaragua ranks 24th of 65 countries.
- Where does this data come from?
- World Intellectual Property Organization (WIPO) (2025) β processed by Our World in Data, published as Life science patents granted, by technology. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of pharmaceutical patents granted by the filing office in a given year. Pharmaceutical patents typically cover new drugs, biological treatments or vaccines.